Our findings reported herein provide additional support for the idea that BMAL1 is an important partner in HIF2α-driven gene regulation and show that this is relevant to ccRCC, in which HIF2α is a key driver. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.